Clinical trial · Observational
Surgical Strategy for Head and Neck Adenoid Cystic Cancer
Refining Surgical Strategies Based on Tumor Staging in Head and Neck Adenoid Cystic Carcinoma: Evidence from a Retrospective Cohort Study
NCT06778915CI-TRIAL-00084798completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To investigate the relationship between surgical margins and outcomes across different tumor stages, in order to provide evidence and guidance for refining stage-specific surgical approaches.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adenoid Cystic Carcinoma | Adenoid Cystic Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Local control
- timeFrame
- 5 year
- description
- defined as the absence of tumor persistence, recurrence, or progression at the primary tumor site following the completion of treatment, assessed by clinical examination and imaging at designated follow-up intervals.
Secondary outcomes (3)
- measure
- Locoregional Recurrence-Free Survival (LRRFS)
- timeFrame
- 5 year
- description
- time from treatment initiation to either locoregional recurrence or death from any cause
- measure
- Overall Survival (OS)
- timeFrame
- 5 year
- description
- time from treatment initiation to death from any cause
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients who underwent surgical resection with curative intent and PORT. Exclusion Criteria: * underwent only biopsy, presented with distant metastases or second primary malignancies at initial diagnosis, had incomplete clinical or histopathologic data, or had histologic evidence of high-grade transformation.
References
Publications (0)
Data not yet available
No reference posted for this study.